Taysha Gene Therapies (TSHA) Non-Current Assets (2020 - 2026)
Taysha Gene Therapies (TSHA) recorded Non-Current Assets of $9 million in Q2 2026, down 47.3% from $17.07 million a year earlier and down 50.3% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Taysha Gene Therapies reported Non-Current Assets of $18.67 million, up 2.4% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of 79.5% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $18.23 million in FY2024 (-20.2%), $22.86 million in FY2023 (-23.4%), $29.86 million in FY2022 (-45.1%) and $54.35 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q1 2021.
- On a year-over-year basis, Non-Current Assets rose in two of the last eight quarters, with an average decline of 17.4%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 89.5% in Q2 2022, against a decline of 65.0% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $18.1 million (Q1 2026), $18.67 million (Q4 2025) and $16.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Taysha Gene Therapies | 1.52 Bn | 173.19 Mn | - | 9.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.00 Mn |
| Mar 31, 2026 | 18.10 Mn |
| Dec 31, 2025 | 18.67 Mn |
| Sep 30, 2025 | 16.60 Mn |
| Jun 30, 2025 | 17.07 Mn |
| Mar 31, 2025 | 17.65 Mn |
| Dec 31, 2024 | 18.23 Mn |
| Sep 30, 2024 | 18.66 Mn |
| Jun 30, 2024 | 21.92 Mn |
| Mar 31, 2024 | 22.40 Mn |
| Dec 31, 2023 | 22.86 Mn |
| Sep 30, 2023 | 23.96 Mn |
| Jun 30, 2023 | 27.43 Mn |
| Mar 31, 2023 | 29.24 Mn |
| Dec 31, 2022 | 29.86 Mn |
| Sep 30, 2022 | 68.47 Mn |
| Jun 30, 2022 | 65.50 Mn |
| Mar 31, 2022 | 59.09 Mn |
| Dec 31, 2021 | 54.35 Mn |
| Sep 30, 2021 | 43.87 Mn |
API Access
Taysha Gene Therapies Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();